Академический Документы
Профессиональный Документы
Культура Документы
Hepatitis A (HepA)
≤18 yrs; 0.5 mL
IM age needle
injection site
≥19 yrs; 1.0 mL length
5/8" Fatty tissue over anterolateral
Hepatitis B (HepB) ≤19 yrs: 0.5 mL Infants
(1–12 mos) thigh muscle
* Persons 11–15 yrs may be given Recombivax HB (Merck) IM
1.0 mL adult formulation on a 2-dose schedule.
≥20 yrs: 1.0 mL
Fatty tissue over anterolateral
0.5 mL IM Children 12 mos or older, 5/8"
Human papillomavirus (HPV) thigh muscle or fatty tissue
adolescents, and adults
over triceps
Intranasal
Influenza, live attenuated (LAIV) 0.2 mL spray
Intramuscular (IM) injection
Influenza, inactivated (IIV) and 6–35 mos: 0.25 mL Use a 22–25 gauge needle. Choose the injection site and needle length
IM
recombinant (RIV) ≥3 yrs: 0.5 mL that is appropriate to the person’s age and body mass.
Influenza (IIV) Fluzone Intradermal, 0.1 mL ID age needle
injection site
for ages 18 through 64 years length
Newborns (1st 28 days) 5/8"* Anterolateral thigh muscle
Measles, Mumps, Rubella (MMR) 0.5 mL SC
Meningococcal conjugate (MCV) 0.5 mL IM Infants (1–12 months) 1" Anterolateral thigh muscle
Intramuscular (IM) injection Subcutaneous (SC) injection Intradermal (ID) administration Intranasal (IN) administration
of Fluzone ID vaccine of Flumist (LAIV) vaccine
90° angle
90° angle 45° angle
Administer
skin skin in area
subcutaneous tissue of deltoid
subcutaneous tissue
muscle muscle
Technical content reviewed by the Centers for Disease Control and Prevention